News
Filter
-
Celebrating our inspirational women scientists
-
New approach provides potential vaccine and treatment for Alzheimer’s
-
LifeArc scientist wins prestigious Industrial Fellowship
-
Industrialising academic-led gene therapies
-
Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases
-
Kickstart drug repurposing: smashing the roadblocks on the route to patients
-
LifeArc publishes expert advice to support work around repurposing medicines
-
Repurposing drugs: the opportunity and the challenges
-
LifeArc and MRC partnership creates new £16m fund to establish Gene Therapy Innovation Hubs
-
LifeArc monetises Keytruda® royalty interests to fund further research and investment
-
Keytruda receives another breakthrough designation
-
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
